# Editas Medicine, Inc.: Form 8-K, filed Jun 8, 2018

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2018-06-08
- Accepted by EDGAR: Jun 8, 2018, 16:01 ET
- Period: 2018-06-07
- Accession: 0001558370-18-005194
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000155837018005194/f8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000155837018005194/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000155837018005194/f8-k.htm

Filed Jun 8, 2018.
Source: SEC EDGAR, the filing index for accession 0001558370-18-005194. Last ingested by Listed: Nov 6, 2026, 17:42 ET. No prices; not investment advice.
